| abstract |
ACTIVE AGENT FORMULATIONS, MANUFACTURING METHODS, AND METHODS OF USE. Active agent compositions are disclosed comprising the active agent particles having an average effective particle size of less than 2000 nm, wherein the compositions comprise a sequestering particle. Compositions having an effective average particle size of less than 2000 nm are also disclosed, wherein the compositions do not comprise any surfactant, phospholipids, or added combination thereof. In some embodiments, the active agent is fenofibrate. In other embodiments, the fenofibrate compositions are in a form of treatment that is bioequivalent to TriCor <32> 145 mg or 48 mg. |